On Wednesday, Fossil Group Inc (NASDAQ:FOSL)’s shares declined -6.74% to $80.63.
Fossil Group Inc (FOSL) stated its financial results for the fiscal quarter ended April 4, 2015. Results for the first quarter of fiscal 2015 comprised of thirteen weeks contrast to a fourteen week period in fiscal 2014. In the first quarter of fiscal 2015, the translation impact from the strengthening of the U.S. dollar negatively influenced net sales by $45.2 million and reduced diluted EPS by $0.13. On a constant currency basis and not taking into account the additional week, first quarter net sales raised 5%.
First Quarter Fiscal 2015 Revenue Summary
In the first quarter of fiscal 2015, stated worldwide net sales reduced 7% or $51.4 million driven by the negative impact of changes in foreign currency and an extra week in the first quarter of fiscal 2014. The following table provides a summary of net sales performance contrast to the first quarter of fiscal 2014.
Fossil Group, Inc., together with its auxiliaries, designs, develops, markets, and distributes consumer fashion accessories. The company operates through four segments: North America Wholesale, Europe Wholesale, Asia Pacific Wholesale, and Direct to Consumer.
Adaptimmune Therapeutics plc (NASDAQ:ADAP)’s shares dropped -5.88% to $16.00.
Adaptimmune Therapeutics plc (ADAP) declared the pricing of its initial public offering of 11,250,000 American Depositary Shares (ADSs) at a price to the public of $17.00 per ADS. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 1,687,500 ADSs. The ADSs are predictable to start trading on the NASDAQ Global Select Market under the symbol “ADAP” on May 6, 2015. The offering is predictable to close on May 11, 2015, subject to customary closing conditions. Adaptimmune estimates net proceeds from the offering will be about $175.7 million.
BofA Merrill Lynch, Cowen and Company and Leerink Partners LLC are acting as joint book-running managers and Guggenheim Securities is acting as lead manager for the offering.
Adaptimmune Therapeutics plc is focused on the use of T cell therapy to treat cancer. Established in 2008 with a research base in Oxford, UK and a clinical base in Philadelphia, US, the company aims to utilize the body’s own machinery – the T cell – to target and destroy cancerous cells by using engineered, raised affinity T cell receptor (TCRs) as a means of strengthening natural patient T cell responses.
At the end of Wednesday’s trade, Cenovus Energy Inc (USA) (NYSE:CVE)‘s shares dipped -5.87% to $17.33.
Cenovus Energy Inc (USA) (CVE) achieved solid production growth in the first quarter contrast with the same period in 2014, driven by 20% higher production at the company’s oil sands operations. Oil sands per-unit operating costs were 31% lower than in the first quarter of 2014, primarily due to higher production and a decrease in fuel costs. Cash flow in the quarter declined 45% as a result of lower crude oil and natural gas sales prices and lower average market crack spreads.
Production from Cenovus’s jointly owned Christina Lake and Foster Creek oil sands operations averaged more than 144,000 bbls/d net in the first quarter. During the quarter, Christina Lake production raised 16% contrast with the same period a year earlier, averaging more than 76,000 bbls/d net.
Cenovus Energy Inc. is a Canadian integrated oil company. It is committed to applying fresh, progressive thinking to safely and responsibly unlock energy resources the world needs. Operations comprise oil sands projects in northern Alberta, which use specialized methods to drill and pump the oil to the surface and established natural gas and oil production in Alberta and Saskatchewan
Gold Fields Limited (ADR) (NYSE:GFI), ended its Wednesday’s trading session with -6.36% loss, and closed at $4.12.
Gold Fields Limited (ADR) (GFI) declared net losses attributable to our shareholders of US$14 million for the March 2015 quarter contrast with US$26 million in the December 2014 quarter and US$nil in the March 2014 quarter. Normalised losses of US$13 million for the March 2015 quarter contrast with earnings of US$17 million in the December 2014 quarter and US$21 million in the March 2014 quarter.
Gold Fields Limited operates as a gold mining company. The company engages in the exploration, extraction, processing, and smelting of gold and copper properties. It holds interests in eight operating mines in South Africa, Ghana, Australia, and Peru.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
